Biodesix, Inc. (BDSX) DCF Valuation

Biodesix, Inc. (BDSX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Biodesix, Inc. (BDSX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Assess Biodesix, Inc.'s (BDSX) financial outlook like an expert! This (BDSX) DCF Calculator provides pre-filled financial data along with the flexibility to modify revenue growth, WACC, margins, and other crucial assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 24.6 45.6 54.5 38.2 49.1 61.8 77.9 98.1 123.5 155.5
Revenue Growth, % 0 85.55 19.64 -29.89 28.46 25.94 25.94 25.94 25.94 25.94
EBITDA -24.9 -20.8 -35.5 -53.8 -37.1 -47.8 -60.2 -75.8 -95.4 -120.2
EBITDA, % -101.52 -45.75 -65.08 -140.74 -75.59 -77.28 -77.28 -77.28 -77.28 -77.28
Depreciation 2.8 2.9 3.2 3.6 5.5 5.5 6.9 8.7 10.9 13.8
Depreciation, % 11.38 6.37 5.83 9.41 11.22 8.84 8.84 8.84 8.84 8.84
EBIT -27.7 -23.7 -38.7 -57.4 -42.6 -50.7 -63.8 -80.4 -101.2 -127.5
EBIT, % -112.9 -52.12 -70.91 -150.15 -86.81 -81.97 -81.97 -81.97 -81.97 -81.97
Total Cash 5.3 62.1 32.7 43.1 26.3 41.4 52.2 65.7 82.8 104.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 5.3 15.3 3.7 5.1 7.7
Account Receivables, % 21.55 33.59 6.71 13.25 15.64
Inventories .8 3.2 2.9 1.4 1.4 2.7 3.4 4.3 5.5 6.9
Inventories, % 3.26 7.02 5.32 3.66 2.85 4.42 4.42 4.42 4.42 4.42
Accounts Payable 1.7 9.0 1.7 1.7 2.9 5.0 6.2 7.9 9.9 12.5
Accounts Payable, % 6.99 19.68 3.05 4.41 5.97 8.02 8.02 8.02 8.02 8.02
Capital Expenditure -1.4 -2.2 -2.5 -3.5 -23.1 -8.8 -11.1 -14.0 -17.6 -22.2
Capital Expenditure, % -5.77 -4.78 -4.67 -9.25 -46.98 -14.29 -14.29 -14.29 -14.29 -14.29
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -28.3 -27.6 -39.8 -70.5 -42.6 -50.7 -63.8 -80.4 -101.2 -127.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -31.3 -32.1 -34.6 -70.3 -61.5 -56.9 -70.4 -88.7 -111.7 -140.6
WACC, % 12.02 12.02 12.02 12.02 12.02 12.02 12.02 12.02 12.02 12.02
PV UFCF
SUM PV UFCF -320.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -143
Terminal Value -1,431
Present Terminal Value -812
Enterprise Value -1,132
Net Debt 34
Equity Value -1,167
Diluted Shares Outstanding, MM 82
Equity Value Per Share -14.21

What You Will Receive

  • Pre-Filled Financial Model: Biodesix’s actual data allows for accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
  • Real-Time Calculations: Automatic updates provide immediate results as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
  • Customizable and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Comprehensive BDSX Data: Pre-filled with Biodesix's historical performance metrics and future projections.
  • Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax implications, and capital investments.
  • Dynamic Valuation Model: Real-time updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Testing: Develop various forecasting scenarios to evaluate different valuation possibilities.
  • User-Friendly Interface: Intuitive, organized, and tailored for both experienced professionals and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template containing Biodesix, Inc. (BDSX) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including the intrinsic value of Biodesix, Inc. (BDSX).
  • Step 5: Use the outputs to make informed investment decisions or create detailed reports.

Why Choose Biodesix, Inc. (BDSX) Calculator?

  • Accuracy: Utilizes real Biodesix financial data for precise calculations.
  • Flexibility: Allows users to easily adjust and test various input parameters.
  • Time-Saving: Eliminate the need to create a financial model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for Biodesix, Inc. (BDSX) analysis.
  • Biotech Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Biodesix, Inc. (BDSX).
  • Students and Educators: Utilize real-world data to practice and teach financial modeling in the biotech sector.
  • Life Sciences Enthusiasts: Gain insights into how biotech companies like Biodesix, Inc. (BDSX) are valued in the market.

What the Template Contains

  • Historical Data: Includes Biodesix, Inc.'s (BDSX) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Biodesix, Inc.'s (BDSX) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Biodesix, Inc.'s (BDSX) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.